Phenotypic Analysis of Epilepsy in the Mitochondrial Encephalomyopathy, Lactic Acidosis, and Strokelike Episodes–Associated Mitochondrial DNA A3243G Mutation
暂无分享,去创建一个
[1] Hoon-Chul Kang,et al. Mitochondrial disease and epilepsy , 2013, Brain and Development.
[2] L. Bindoff,et al. Acute mitochondrial encephalopathy reflects neuronal energy failure irrespective of which genome the genetic defect affects. , 2012, Brain : a journal of neurology.
[3] M. Tarnopolsky,et al. The psychiatric presentation of mitochondrial disorders in adults. , 2012, The Journal of neuropsychiatry and clinical neurosciences.
[4] T. Matsuishi,et al. Molecular pathology of MELAS and L-arginine effects. , 2012, Biochimica et biophysica acta.
[5] R. Saneto,et al. Dravet syndrome: Patients with co-morbid SCN1A gene mutations and mitochondrial electron transport chain defects , 2011, Seizure.
[6] Josemir W Sander,et al. Impaired mitochondrial energy production: the basis of pharmacoresistance in epilepsy. , 2011, Medical hypotheses.
[7] K. Kaufman,et al. MELAS with recurrent complex partial seizures, nonconvulsive status epilepticus, psychosis, and behavioral disturbances: Case analysis with literature review , 2010, Epilepsy & Behavior.
[8] K. Majamaa,et al. Digenic mutations in severe myoclonic epilepsy of infancy , 2009, Epilepsy Research.
[9] B. Kosofsky,et al. MELAS With A3243G Mutation Presenting With Occipital Status Epilepticus , 2009, Journal of child neurology.
[10] Hoon-Chul Kang,et al. Mitochondrial respiratory chain defects: Underlying etiology in various epileptic conditions , 2008, Epilepsia.
[11] K. Majamaa,et al. Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children , 2007, Annals of neurology.
[12] Y. Toribe,et al. [Usefulness of L-arginine infusion for status epilepticus in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes]. , 2007, No to hattatsu = Brain and development.
[13] P. Thajeb,et al. Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA , 2007, Metabolic Brain Disease.
[14] G. Rosati,et al. “Erratic” complex partial status epilepticus as a presenting feature of MELAS , 2006, Epilepsy & Behavior.
[15] A. Mitsudome,et al. An infant with a mitochondrial A3243G mutation demonstrating the MELAS phenotype. , 2006, Pediatric neurology.
[16] J. Salas-Puig,et al. [Characteristics of status epilepticus in MELAS. Analysis of four cases]. , 2006, Neurologia.
[17] S. Fujimoto,et al. l-Arginine improves the symptoms of strokelike episodes in MELAS , 2005, Neurology.
[18] H. Bokura,et al. Successful treatment with succinate in a patient with MELAS. , 2004, Internal medicine.
[19] T. Matsuishi,et al. Effects of L-arginine on the acute phase of strokes in three patients with MELAS. , 2002, Neurology.
[20] M. Zeviani,et al. Epileptic phenotypes associated with mitochondrial disorders , 2001, Neurology.
[21] A. Leff,et al. Brief Communication Complex Partial Status Epilepticus in Late‐Onset MELAS , 1998, Epilepsia.
[22] T. Yasuda,et al. Periodic lateralized epileptiform discharges in mitochondrial encephalomyopathy. , 1997, Electroencephalography and clinical neurophysiology.
[23] M. C. Han,et al. Mitochondrial myopathy-encephalopathy-lactic acidosis-and strokelike episodes (MELAS) syndrome: CT and MR findings in seven children. , 1996, AJR. American journal of roentgenology.
[24] S. Dimauro,et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: A distinctive clinical syndrome , 1984, Annals of neurology.